19-46693973-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000291281.9(PRKD2):āc.1478G>Cā(p.Gly493Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00165 in 1,613,084 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0088 ( 19 hom., cov: 33)
Exomes š: 0.00091 ( 19 hom. )
Consequence
PRKD2
ENST00000291281.9 missense
ENST00000291281.9 missense
Scores
8
10
Clinical Significance
Conservation
PhyloP100: 5.93
Genes affected
PRKD2 (HGNC:17293): (protein kinase D2) The protein encoded by this gene belongs to the protein kinase D (PKD) family of serine/threonine protein kinases. This kinase can be activated by phorbol esters as well as by gastrin via the cholecystokinin B receptor (CCKBR) in gastric cancer cells. It can bind to diacylglycerol (DAG) in the trans-Golgi network (TGN) and may regulate basolateral membrane protein exit from TGN. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00446558).
BP6
Variant 19-46693973-C-G is Benign according to our data. Variant chr19-46693973-C-G is described in ClinVar as [Benign]. Clinvar id is 781493.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00875 (1333/152330) while in subpopulation AFR AF= 0.0289 (1201/41570). AF 95% confidence interval is 0.0275. There are 19 homozygotes in gnomad4. There are 613 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1333 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKD2 | NM_016457.5 | c.1478G>C | p.Gly493Ala | missense_variant | 10/18 | ENST00000291281.9 | NP_057541.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKD2 | ENST00000291281.9 | c.1478G>C | p.Gly493Ala | missense_variant | 10/18 | 1 | NM_016457.5 | ENSP00000291281 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00874 AC: 1331AN: 152212Hom.: 19 Cov.: 33
GnomAD3 genomes
AF:
AC:
1331
AN:
152212
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00221 AC: 551AN: 248964Hom.: 11 AF XY: 0.00172 AC XY: 232AN XY: 134874
GnomAD3 exomes
AF:
AC:
551
AN:
248964
Hom.:
AF XY:
AC XY:
232
AN XY:
134874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000906 AC: 1323AN: 1460754Hom.: 19 Cov.: 31 AF XY: 0.000758 AC XY: 551AN XY: 726706
GnomAD4 exome
AF:
AC:
1323
AN:
1460754
Hom.:
Cov.:
31
AF XY:
AC XY:
551
AN XY:
726706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00875 AC: 1333AN: 152330Hom.: 19 Cov.: 33 AF XY: 0.00823 AC XY: 613AN XY: 74478
GnomAD4 genome
AF:
AC:
1333
AN:
152330
Hom.:
Cov.:
33
AF XY:
AC XY:
613
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
116
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
355
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D;D;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;D;T;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M;.;M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
.;D;D;.;.
REVEL
Benign
Sift
Benign
.;D;D;.;.
Sift4G
Benign
T;T;T;T;T
Polyphen
0.98
.;D;D;.;.
Vest4
MVP
MPC
1.8
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at